---
title: "WEIGUANG released its first-quarter performance, with a net profit attributable to the parent company of 86.9468 million yuan, a year-on-year increase of 19.39%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237808013.md"
description: "According to the Zhitong Finance APP, WEIGUANG released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 356 million yuan, a year-on-year increase of 12.69%. The net profit attributable to shareholders of the listed company was 86.9468 million yuan, a year-on-year increase of 19.39%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 73.9836 million yuan, a year-on-year increase of 2.64%"
datetime: "2025-04-28T09:19:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237808013.md)
  - [en](https://longbridge.com/en/news/237808013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237808013.md)
---

# WEIGUANG released its first-quarter performance, with a net profit attributable to the parent company of 86.9468 million yuan, a year-on-year increase of 19.39%

According to the Zhitong Finance APP, WEIGUANG (002801.SZ) released its Q1 2025 report. In the first quarter, the company achieved an operating income of 356 million yuan, a year-on-year increase of 12.69%. The net profit attributable to shareholders of the listed company was 86.9468 million yuan, a year-on-year increase of 19.39%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 73.9836 million yuan, a year-on-year increase of 2.64%

### Related Stocks

- [002801.CN](https://longbridge.com/en/quote/002801.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [10:19 ETAARC-360 Completes AICPA Peer Review with Pass Rating](https://longbridge.com/en/news/286929747.md)
- [US cyber agency CISA exposed reams of passwords and cloud keys to the open web](https://longbridge.com/en/news/286937105.md)
- [Stocks to buy: Tata Communications, Nibe, ELGI Equipments on analyst radar](https://longbridge.com/en/news/287141880.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)